Skitahoe Portfolio 1
536 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by Skitahoe
DESCRIPTION:

Date updated:11-19-2007

I hold a number of stocks that I believe could have explosive growth, but many are selling for pennies or less, and they certainly could go out of business.

symbol name last price % change open
  • +
  • IMGN
    Immunogen
  • $7.99
  • +8.12%
  • $7.30

I've held this stock essentially since its start in 1990, while it certainly hasn't done what I hoped for, today it has more to offer than ever before. There are currently five drugs in trials, licenses for eight more anticipated in trials over the next few years. More importantly, by August of 2008 SNY should license ten or more new licenses, and several other new licenses are expected. The key is reaching drug approval, and that will take a few years, but when it happens this company's stock could split multiple times because of the number of drugs that are following it.

People owning IMGN also tend to own: CLRKDUKFTEKHWIVANMNGSSW

TheStreet.com Rating: D What is this?

  • +
  • CTKH.PK
    Cetek Tech Inc Ne
  • $0.0001
  • 0.00%
  • $N/A

Cetek is involved with the specialty ceramics that are involved in all sorts of electronics including flat panel displays. If the information regarding the Cetek Process is true, they've developed ways of producing very high quality thin ceramic films that require little or no machining. Furthermore, if true they also have much shorter processing time then the competition which often has it's products in the ovens for about a week. It's highly speculative, the CEO doesn't properly report quarterly or other results, but appears to be the brilliant genius who developed the process and improve on it. There are over 5 billion shares outstanding, but if earnings are positive, this stock could easily rise to the pennies, instead of being subpenny, percentage wise that would be huge.

People owning CTKH.PK also tend to own: APPI.OBCEXI.OBDNDNGNVCIMGNMDOR.OB

TheStreet.com Rating: No Rating What is this?

  • +
  • GNVC
    Genvec
  • $0.8798
  • 0.00%
  • $N/A

A recent acquisition based on a drug that appears headed for approval. I expect rapid appreciation on approval of the drug. I don't see the kind of platform IMGN has, but they do have a platform and I really like platform technologies. They are also working with Homeland Security on a vaccine for foot and mouth disease. It's a strong endorsement of the technology they're developing.

People owning GNVC also tend to own: ACORCRISALKSALNYARNAARWRASPV

TheStreet.com Rating: D- What is this?

  • +
  • CEXI.OB
    Cdex Inc Cl A
  • $0.055
  • 0.00%
  • $N/A

They have developed unique detectors for validating the correct contents of drugs, and are working on devices that can determine liquor, wines, etc are counterfeit. They also are working on detection of explosives and illegal drugs. They appear to have some unique technologies which if proven could grow rapidly especailly in the current environment. Right now they're struggling to fund development, but growth could be big if someone likes what they see.

People owning CEXI.OB also tend to own: APPI.OBCTKH.PKDNDNGNVCIMGNMDOR.OBBCLI.OB

TheStreet.com Rating: No Rating What is this?

  • +
  • MDOR.OB
    Magnum D Or Resou
  • $1.18
  • 0.00%
  • $N/A

Currently in the process of reinventing themselves. Don't know precisely where they'll go but they've moved up substantially since the new CEO came aboard. The mines I originally invested for will apparently be spun of to another new company which investors will receive stock in.

People owning MDOR.OB also tend to own: APPI.OBCEXI.OBCTKH.PKDNDNGNVCIMGNAVRX

TheStreet.com Rating: No Rating What is this?

  • +
  • DNDN
    Dendreon Corporat
  • $28.61
  • +2.99%
  • $28.18

I purchased some Feb 7.50 calls as they are extremely low priced and with all the volatility in the stock should offer the opportunity for quick profit. Should the news of either approval or major partnership occur before they expire the stock could easily reach $20 or more permitting me to purchase either all the shares on margin, or most of them by selling a small portion of what I optioned.

People owning DNDN also tend to own: GLWUNHACASAHMATBAUYBRLC

TheStreet.com Rating: D- What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...

11.09.09 | 11:01 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...

11.09.09 | 08:04 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
more articles
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
more forums
Q. wow big pappa your up late thank...
11.09.09 | 23:58 PM Asked by dartboardtrader

A. West Coast...Not that late
G'nite

today 's lists
Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Nov. 2, 2009. more

Analyst Downgrades

Analyst Downgrades for Nov. 2, 2009. Read more here. more

52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more